Johnson & Johnson (JNJ)

270.24
+2.87 (1.07%)
NYSE· Last Trade: Aug 21st, 4:17 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close267.37
Open267.83
Bid270.24
Ask272.00
Day's Range267.00 - 272.66
52 Week Range173.33 - 276.47
Volume6,144,892
Market Cap710.37B
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield5.360 (1.98%)
1 Month Average Volume7,172,465

Chart

About Johnson & Johnson (JNJ)

Johnson & Johnson is a multinational corporation engaged in the development, manufacturing, and marketing of a wide range of healthcare products. The company operates through three primary segments: pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for its commitment to innovation in healthcare, producing a diverse array of products that include prescription medications for various diseases, sophisticated medical devices for surgical procedures, and widely recognized consumer brands for personal care and wellness. With a focus on improving health outcomes, the company aims to address the evolving needs of patients and consumers around the world. Read More

News & Press Releases

Discover which dow jones stocks are making waves on Friday.chartmill.com
Via Chartmill · August 21, 2026
Stay informed with the top movers within the dow jones index on Friday.chartmill.com
Via Chartmill · August 21, 2026
Which dow jones stocks are moving on Thursday?chartmill.com
Via Chartmill · August 20, 2026
Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Futurefool.com
Johnson & Johnson's new drugs may offset declining sales due to patent-protection losses.
Via The Motley Fool · August 20, 2026
Johnson & Johnson (NYSE:JNJ): A Dividend Quality Standoutchartmill.com
Via Chartmill · August 17, 2026
Johnson & Johnson Expands Robotic Bronchoscopy Push With AI, 3D Navigation Upgradebenzinga.com
Johnson & Johnson secures FDA clearance for MONARCH QUEST 3 software, boosting robotic bronchoscopy accuracy with AI. new 3D imaging tools.
Via Benzinga · August 19, 2026
Warren Buffett Thinks Investors Are "Gambling" and "Playing With Fire" Right Now. But Here Are 3 Safe Stocks Even the Oracle of Omaha Would Like.fool.com
While investors treat Wall Street like a casino, stick to these Buffett-style "wonderful investments."
Via The Motley Fool · August 19, 2026
Thinking About Buying SpaceX? These 2 Stocks Should Be Better Betsfool.com
The space company is popular right now, but these other corporations look more attractive.
Via The Motley Fool · August 18, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · August 18, 2026
Which dow jones stocks are moving on Tuesday?chartmill.com
Via Chartmill · August 18, 2026
Discover which dow jones stocks are making waves on Monday.chartmill.com
Via Chartmill · August 17, 2026
Uncover the latest developments among dow jones stocks in today's session.chartmill.com
Via Chartmill · August 17, 2026
What's going on in today's session: dow jones moverschartmill.com
Via Chartmill · August 14, 2026
Which dow jones stocks are moving on Friday?chartmill.com
Via Chartmill · August 14, 2026
Recession-Proofing Your Portfolio Before the Storm Hitsfool.com
Whether a recession is coming in 2026 or five years from now, the best investors are always figuring out how to prepare.
Via The Motley Fool · August 13, 2026
Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested Pays Annually.fool.com
The pharmaceutical giant just increased its dividend by 3.1%, now paying $5.36 a share annually.
Via The Motley Fool · August 13, 2026
The U.S. Labor Market Is Weakening. These 2 Dividend Stocks Look Built to Weather a Recessionfool.com
These stocks can help you withstand (almost) any storm.
Via The Motley Fool · August 11, 2026
Uncover the latest developments among dow jones stocks in today's session.chartmill.com
Via Chartmill · August 11, 2026
Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Johnson & Johnson (NYSE: JNJ) will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14th, 2026. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time.
By Johnson & Johnson · Via Business Wire · August 10, 2026
5 Stocks the Market Rewarded After Strong Earnings Resultsmarketbeat.com
Amazon, Microsoft, JPMorgan Chase, Johnson & Johnson and Coca-Cola posted strong earnings beats that held up, with cloud growth, capital returns and raised guidance fueling sustained stock gains.
Via MarketBeat · August 10, 2026
Build Dividend Income at Low Cost With These ETFsdividendstocks.com
VYM, VCIT, and AGG offer low-cost ETF options for income investors, combining dividend yields between 2.20% and 4.86% with broad diversification and expense ratios as low as 0.03%.
Via MarketBeat · August 10, 2026
Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested in the Dividend King Pays Annually.fool.com
The pharmaceutical icon's dividend yield has been pared back by the stock's recent rally, driven by a new growth initiative.
Via The Motley Fool · August 9, 2026
Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?fool.com
They are going through a rough patch, but it's too early to give up on them.
Via The Motley Fool · August 8, 2026
Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTechfool.com
Intuitive Surgical is a leader in the surgical robotics space, with a large installed base and strong recurring revenues.
Via The Motley Fool · August 8, 2026
Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?fool.com
XLV's concentrated 60-stock portfolio beat VHT's broader 423 holdings over five years, though VHT delivered stronger 1-year returns.
Via The Motley Fool · August 8, 2026